These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Monocyte chemoattractant protein-1 regulation of blood-brain barrier permeability. Stamatovic SM; Shakui P; Keep RF; Moore BB; Kunkel SL; Van Rooijen N; Andjelkovic AV J Cereb Blood Flow Metab; 2005 May; 25(5):593-606. PubMed ID: 15689955 [TBL] [Abstract][Full Text] [Related]
8. Low-dose endothelial monocyte-activating polypeptide-II increases permeability of blood-tumor barrier via a PKC-ζ/PP2A-dependent signaling mechanism. Li Z; Liu YH; Liu XB; Xue YX; Wang P; Liu LB Exp Cell Res; 2015 Feb; 331(2):257-66. PubMed ID: 25592443 [TBL] [Abstract][Full Text] [Related]
10. RhoA/ROCK-2 Pathway Inhibition and Tight Junction Protein Upregulation by Catalpol Suppresses Lipopolysaccaride-Induced Disruption of Blood-Brain Barrier Permeability. Feng S; Zou L; Wang H; He R; Liu K; Zhu H Molecules; 2018 Sep; 23(9):. PubMed ID: 30227623 [TBL] [Abstract][Full Text] [Related]
11. Ethanol-induced activation of myosin light chain kinase leads to dysfunction of tight junctions and blood-brain barrier compromise. Haorah J; Heilman D; Knipe B; Chrastil J; Leibhart J; Ghorpade A; Miller DW; Persidsky Y Alcohol Clin Exp Res; 2005 Jun; 29(6):999-1009. PubMed ID: 15976526 [TBL] [Abstract][Full Text] [Related]
12. Roles of Serine/Threonine Phosphatases in Low-Dose Endothelial Monocyte-Activating Polypeptide-II-Induced Opening of Blood-Tumor Barrier. Li Z; Liu XB; Liu YH; Xue YX; Wang P; Liu LB; Liu J; Yao YL; Ma J J Mol Neurosci; 2015 Sep; 57(1):11-20. PubMed ID: 26087743 [TBL] [Abstract][Full Text] [Related]
13. Rho and Rho kinase are involved in parathyroid hormone-stimulated protein kinase C alpha translocation and IL-6 promoter activity in osteoblastic cells. Radeff JM; Nagy Z; Stern PH J Bone Miner Res; 2004 Nov; 19(11):1882-91. PubMed ID: 15476589 [TBL] [Abstract][Full Text] [Related]
14. Long-term exposure to ethanol downregulates tight junction proteins through the protein kinase Cα signaling pathway in human cerebral microvascular endothelial cells. Yu H; Wang C; Wang X; Wang H; Zhang C; You J; Wang P; Feng C; Xu G; Zhao R; Wu X; Zhang G Exp Ther Med; 2017 Nov; 14(5):4789-4796. PubMed ID: 29201181 [TBL] [Abstract][Full Text] [Related]
15. Signal mechanisms underlying low-dose endothelial monocyte-activating polypeptide-II-induced opening of the blood-tumor barrier. Li Z; Liu YH; Xue YX; Liu LB; Wang P J Mol Neurosci; 2012 Sep; 48(1):291-301. PubMed ID: 22531886 [TBL] [Abstract][Full Text] [Related]
16. The active Zot domain (aa 288-293) increases ZO-1 and myosin 1C serine/threonine phosphorylation, alters interaction between ZO-1 and its binding partners, and induces tight junction disassembly through proteinase activated receptor 2 activation. Goldblum SE; Rai U; Tripathi A; Thakar M; De Leo L; Di Toro N; Not T; Ramachandran R; Puche AC; Hollenberg MD; Fasano A FASEB J; 2011 Jan; 25(1):144-58. PubMed ID: 20852064 [TBL] [Abstract][Full Text] [Related]
17. Simvastatin alleviates hyperpermeability of glomerular endothelial cells in early-stage diabetic nephropathy by inhibition of RhoA/ROCK1. Peng H; Luo P; Li Y; Wang C; Liu X; Ye Z; Li C; Lou T PLoS One; 2013; 8(11):e80009. PubMed ID: 24244596 [TBL] [Abstract][Full Text] [Related]
18. RhoA and Rho-kinase dependent and independent signals mediate TGF-beta-induced pulmonary endothelial cytoskeletal reorganization and permeability. Clements RT; Minnear FL; Singer HA; Keller RS; Vincent PA Am J Physiol Lung Cell Mol Physiol; 2005 Feb; 288(2):L294-306. PubMed ID: 15475381 [TBL] [Abstract][Full Text] [Related]
19. Deciphering vascular endothelial cell growth factor/vascular permeability factor signaling to vascular permeability. Inhibition by atrial natriuretic peptide. Pedram A; Razandi M; Levin ER J Biol Chem; 2002 Nov; 277(46):44385-98. PubMed ID: 12213803 [TBL] [Abstract][Full Text] [Related]
20. PDCD10 (CCM3) regulates brain endothelial barrier integrity in cerebral cavernous malformation type 3: role of CCM3-ERK1/2-cortactin cross-talk. Stamatovic SM; Sladojevic N; Keep RF; Andjelkovic AV Acta Neuropathol; 2015 Nov; 130(5):731-50. PubMed ID: 26385474 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]